Is It Time for Stand-Alone HPV Testing?
Now that stand-alone HPV tests have been approved, is it worth changing cervical cancer screening recommendations? Juan Felix, MD, weighs in.
Drug Helps Protect Ovaries from Chemotherapy
The GnRH agonist goserelin, when given during chemotherapy, may protect against ovarian failure and early menopause in women with breast cancer.
HRT Unlikely to Have Cardioprotective Effects
Hormone replacement therapy won't protect postmenopausal women against stroke or heart disease, but don't discount it for symptoms of menopause just yet.
Are You Using Enough Force on Breast Exams?
Clinicians conducting breast examinations who don’t apply enough force during palpation risk missing deeper lesions.
Who Needs Genetic Testing for GYN Cancer?
Genetic testing for ovarian or endometrial cancer isn't recommended for everyone. Find out here which patients should be referred for testing.
Comprehensive Care in the Land of Ob/Gyn
Ilene Gewirtz, MD, discusses her comprehensive approach to well visits and cancer screens and says education, if not expanded services, is key.
Current HRT Use Increases Ovarian Cancer Risk
Even brief use of hormone replacement therapy in menopause can increase risk of the 2 most common forms of ovarian cancer, a meta-analysis finds.
Cervical Treatments Don't Hinder Fertility
Treatments to remove precancerous cervical lesions don't seem to affect a woman's ability to become pregnant, new research found.
Advancements in Gynecological Oncology
Could the approval of bevacizumab for advanced cervical cancer and platinum-resistant ovarian cancer last year lead to patient-specific therapies?
The Utility of Vaginal Estrogens for Managing GSM
Vaginal estrogens are effective options for managing bothersome symptoms related to genitourinary syndrome of menopause in postmenopausal women.